Clinical Trials Directory

Trials / Unknown

UnknownNCT01081392

Inflammatory Markers in Sputum After LPS Inhalation

The Role of Inhaled Particle Size on the Inflammatory Response Induced by Endotoxin Inhalation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Centre Hospitalier Universitaire Brugmann · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to measure inflammatory biomarkers in sputum and peripheral blood in healthy volunteers after inhalation of single doses of LPS (20 mcg) administered as particles of different sizes.

Detailed description

Endotoxins are inflammatory substances present in the environment. In man, the inhalation of the lipopolysaccharride moiety (LPS) induces measurable immune responses. With an inhaled single dose of 20 micron, the inflammatory response in man is sub-clinical. During bronchoprovocation tests with allergens, the particle size determines to a large extent the intensity of the response. the response to LPS as a function of particle size is not known and will be studied in this study.

Conditions

Interventions

TypeNameDescription
BIOLOGICALLPSLPS 20mcg sd inhaled via nebulizer, 3 periods

Timeline

Start date
2010-01-01
Primary completion
2010-04-01
Completion
2010-05-01
First posted
2010-03-05
Last updated
2010-03-05

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01081392. Inclusion in this directory is not an endorsement.

Inflammatory Markers in Sputum After LPS Inhalation (NCT01081392) · Clinical Trials Directory